Search
for
Sort by
Research 541–570 of 1000+
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Sex steroid hormones are associated with mortality in COVID-19 patients
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Impact of COVID-19 pandemic among healthcare professionals
- Impact of the COVID-19 Pandemic on Tertiarycare University Dermatology Outpatient Clinic and Dermatology Procedures
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Analyzing the factors and control strategies of COVID-19 in Iraq: A cross-sectional analysis
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Role of ACE2 polymorphism in COVID-19: impact of age
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Correlations between soluble receptor for advanced glycation end products and heme oxogenase-1 in post-COVID-19 patients with telogen effluvium
- Blood group O and post-COVID-19 syndrome
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Collider bias undermines our understanding of COVID-19 disease risk and severity
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Gender differences in patients with COVID-19: a narrative review
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Insights into disparities observed with COVID‐19
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19